tiprankstipranks

Analyst Profile

Followed by 2,657 followers
.
Swayampakula Ramakanth

Swayampakula Ramakanth

H.C. Wainwright
Wall Street Analyst
#7,817 out of 7,962 Wall Street Analysts
#21,774 out of 22,231 experts

Success Rate

28%
129 out of 464 transactions made a profit

Average Return

-13.60%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
Copying Swayampakula Ramakanth's trades since 2015 and holding each position for 1 Year would result in 27.80% of your transactions generating a profit, with an average return of -13.6% per rating.

Stock Rating Distribution

1KRatings
93.30% Buy
6.70% Hold
0.00% Sell
Distribution of Swayampakula Ramakanth's ratings

Additional Information

Main Sector:Healthcare
Geo Coverage:
United StatesUS Market
CanadaCanadian Market
United KingdomUK Market
GermanyGermany Market

Best Rating

Stock:
Zomedica Pharma
(ZOM)
Rating:Buy
Date:Nov 16, 2020 - Nov 16, 2021
Return:+344.60%
The most profitable rating made by Swayampakula Ramakanth

Swayampakula Ramakanth's Stock Coverage

Company
Date
Position
Action
Price Target
No. of Ratings
Success Rate
Avg. Return
Aldeyra Therapeutics
May 14, 2015
Buy
Reiterated
$14.00
(159.74% Upside)
1Ratings
0.00%
Strata Skin Sciences
Aug 24, 2015
Buy
Reiterated
$5.00
(525.00% Upside)
6Ratings
0.00%
Sorrento Therapeutics
Dec 07, 2015
Buy
Assigned
$45.00
(2880.13% Upside)
7Ratings
0.00%
XTL Biopharmaceuticals Ltd. Sponsored ADR
Mar 22, 2016
Buy
Reiterated
$6.00
(338.47% Upside)
1Ratings
0.00%
Rebus Holdings
Mar 28, 2016
Buy
Reiterated
$2.00
(11664.71% Upside)
4Ratings
0.00%
Xtant Medical Holdings
Aug 03, 2016
Buy
Reiterated
5Ratings
0.00%
Imunon
Nov 11, 2016
Buy
Reiterated
$3.00
(87.50% Upside)
3Ratings
0.00%
Capricor Therapeutics
Nov 16, 2016
Buy
Reiterated
2Ratings
0.00%
Immutep
Feb 28, 2017
Buy
Reiterated
$7.50
(371.70% Upside)
4Ratings
0.00%
Kazia Therapeutics
Feb 28, 2017
Buy
Reiterated
$20.00
(1594.92% Upside)
5Ratings
0.00%
List of latest recommendations made by Swayampakula Ramakanth. Click to expand and see Swayampakula Ramakanth's performance on a particular stock
Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed.
Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >